Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Conformations of Cyclohexane02:11

Conformations of Cyclohexane

12.6K
Cyclohexane does not exist in a planar form due to the high angle and torsional strain it would experience in the planar structure. Instead, it adopts non-planar chair and boat conformations.
The chair form is the most stable and derives its name from its resemblance to the “easy chair.” In the chair conformation, two carbon atoms are arranged out-of-plane — one above and one below, minimizing the torsional strain. In the chair form, the bond angle is very close to the ideal...
12.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.

Journal of chemical information and modeling·2025
Same author

Exploring Extended Warheads toward Developing Cysteine-Targeted Covalent Kinase Inhibitors.

Journal of chemical information and modeling·2024
Same author

Deep generative models of protein structure uncover distant relationships across a continuous fold space.

Nature communications·2024
Same author

Advances in reversible covalent kinase inhibitors.

Medicinal research reviews·2024
Same author

Ten simple rules for managing laboratory information.

PLoS computational biology·2023
Same author

How Ligands Interact with the Kinase Hinge.

ACS medicinal chemistry letters·2023
Same journal

Inhibition of Lin-11, Isl-1, and Mec‑3 Kinase (LIMK) Activity Attenuates Astrogliosis and Vascular Remodeling in an Experimental Model of Cuprizone-Induced Demyelination in Mice.

ACS pharmacology & translational science·2026
Same journal

Cyclin-Dependent Kinases 4 and 6 Inhibitors: An Emerging Therapeutic Framework from Growth Suppression to Tumor Clearance.

ACS pharmacology & translational science·2026
Same journal

Sertraline Enhances Bacterial Control without Adversely Affecting the Pharmacodynamic-Pharmacokinetic Properties of Frontline Tuberculosis Drugs.

ACS pharmacology & translational science·2026
Same journal

Repurposing FDA-Approved Drugs as Potential Inhibitors of Feline Infectious Peritonitis Virus 3CL<sup>pro</sup>: An Integrated In Silico and In Vitro Study with Synergistic Combination Analysis.

ACS pharmacology & translational science·2026
Same journal

Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.

ACS pharmacology & translational science·2026
Same journal

Head-to-Head Comparison of Monomeric, Homodimeric, and Heterodimeric Fibroblast Activation Protein-Targeting Radioligands Based on Small Molecule Inhibitor and Cyclic Peptide.

ACS pharmacology & translational science·2026
See all related articles

Related Experiment Video

Updated: Jul 19, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Rigid Scaffolds Are Promising for Designing Macrocyclic Kinase Inhibitors.

Zheng Zhao1, Philip E Bourne1

  • 1School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22904, United States.

ACS Pharmacology & Translational Science
|August 17, 2023
PubMed
Summary
This summary is machine-generated.

Macrocyclic kinase inhibitors (MKIs) offer improved selectivity and drug resistance potential. This study reveals their rigid scaffolds maintain similar binding modes to acyclic precursors, aiding rational MKI design.

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.9K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.9K

Related Experiment Videos

Last Updated: Jul 19, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.9K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

7.9K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Macrocyclic kinase inhibitors (MKIs) show promise for selectivity and overcoming drug resistance.
  • Designing novel MKIs is challenging due to their complex structures.

Purpose of the Study:

  • To facilitate the rational design and discovery of MKIs.
  • To investigate the structural and binding characteristics of MKIs compared to their acyclic precursors.

Main Methods:

  • Performed microsecond-scale atomistic simulations for multiple MKIs.
  • Constructed a comprehensive MKI database.
  • Analyzed MKIs using hierarchical cluster analysis.

Main Results:

  • MKI binding modes resemble those of their acyclic counterparts against kinase targets.
  • MKI scaffolds exhibit rigid conformations, similar to their acyclic precursors, before and after cyclization.
  • Developed a database of 641 nanomole-level MKIs across 56 human kinases.

Conclusions:

  • The rigidity of MKI scaffolds is a key feature for rational design.
  • The established MKI database and findings provide valuable resources for advancing MKI development.
  • Understanding scaffold rigidity aids in overcoming design challenges for novel kinase inhibitors.